Influenza Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033

Influenza Tests Market Overview

The influenza tests market size was valued at $367.3 million in 2022. Influenza tests are diagnostic tests used to detect the presence of the influenza virus in a patient’s respiratory system. The choice of an influenza test depends on a variety of factors, including the severity of the patient’s illness, the timing of the test, and the availability of testing facilities. This segment includes Influenza Antigen Tests, Influenza Multiplex NAATs, and Influenza Lowplex Nucleic Acid Amplification Tests (NAATs). One unit refers to One Influenza test.

Influenza Tests Market Outlook, 2022-2033 ($ Million)

For more insights on the influenza tests market forecast, download a free report sample

Influenza tests market research report is built to visualize quantitative market trends within In Vitro therapeutic area. It discusses in detail the impact of COVID-19 on the influenza tests market for the year 2020 and beyond.

Influenza Tests Market Dynamics

Epidemic influenza causes global public health burden each season. The World Health Organization (WHO) estimates that influenza severely affects between three and five million individuals each year and causes between 250,000 and 500,000 deaths. The influenza attack rate is highest in children, while complications including hospitalization and death occur most frequently in elderly individuals.

Influenza testing is done through three primary PCR tests: Lowplex NAATs, Antigen Tests (including Enzyme Immunoassays, Fluorescence Immunoassays, and Direct Fluorescence detection methods), and Multiplex NAATs. Although, NAATs holds a significant market share and will remain the gold standard of testing due to its established and widespread use, POC Antigen and POC NAAT tests are gaining traction. GlobalData expects Multiplex NAATs to gain in usage with the approach of successive flu seasons, and physician and patient preference will likely be given to such respiratory panels. .

Influenza Tests Market Segmentation by Regions

The key regions in the influenza tests market are North America, Europe, Asia Pacific, South America, and the Middle East & Africa. North America held the largest market share in 2022. The Influenza tests market is expected to grow in Canada and Mexico and decline in the US during the forecast period.

Growth of the Canadian Influenza test markets is largely being driven by increases in the number of incident cases and the number of suspected and confirmatory cases opting for Influenza tests. Sales of Influenza tests in the US are expected to decline at a minor rate due to a decrease in the number of incident cases.

Influenza Tests Market Segments

The key segments in the influenza tests market are Influenza Antigen Tests, Influenza Multiplex NAATs, and Influenza Lowplex Nucleic Acid Amplification Tests (NAATs). Influenza Multiplex NAATs led the market in 2022.

Influenza Tests Market Analysis, by Segments 2022 (%)

To know more about the key segments in the influenza tests market, download a free report sample

Influenza Tests Market - Competitive Landscape

Some of the leading companies in the influenza tests market are Abbott Laboratories, Quidel Corp, Cepheid Inc, DiaSorin SpA, bioMerieux SA, Becton Dickinson and Co, and Qiagen NV. Abbott Laboratories dominated the market in 2022.

Influenza Tests Market Analysis, by Companies 2022 (%)

To know more about the leading companies in the influenza tests market, download a free report sample

Segments Covered in the Report

Influenza Tests Market Segments Outlook (Value, $ Million, 2015-2033)

• Influenza Multiplex NAATs
• Influenza Antigen Tests
• Influenza Lowplex Nucleic Acid Amplification Tests (NAATs)

Influenza Tests Market Regional Outlook (Value, $ Million, 2015-2033)

• North America
• Europe
• Asia Pacific
• South Central America
• Middle East and Africa

Key Inclusions

Currently marketed Influenza Test and evolving competitive landscape:

• Insightful review of the key industry trends.
• Annualized total influenza tests market revenue by segment and market outlooks from
  2015– 2033.
• Market-level data on units, average selling prices, and market values.

Global, Regional, and Country level market specific insights:

• Qualitative market-specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
• SWOT analysis for influenza tests market.
• Competitive dynamics insights and trends provided for the influenza tests market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country-specific overview of the healthcare system.
• Country-specific reimbursement policies.
• Country-specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real-world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Abbott Laboratories, Danaher Corp, Quidelortho Corp, F. Hoffmann-La Roche Ltd, DiaSorin SpA, Becton Dickinson and Co, Qiagen NV, Thermo Fisher Scientific Inc, bioMerieux SA, Sekisui Diagnostics LLC, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for:

• CMO executives who must have deep understanding of the influenza tests market place to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets

Reasons to Buy

The model will enable you to:

• Understand the impact of COVID-19 on the influenza tests market.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving the influenza tests market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the influenza tests market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company’s share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
• Track device sales in the global and country-specific influenza tests market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.